Clinical Trials Directory

Trials / Completed

CompletedNCT06132906

Comparison Between Two Techniques to Reposition the Maxilla After le Fort 1

Comparison of Accuracy Between Novel Locating Guide Design With Pre-bent Titanium Plates and 3d Printed Intermediate Wafer to Reposition the Maxilla After le Fort 1 Osteotomy in Orthognathic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Years – 42 Years
Healthy volunteers
Accepted

Summary

clinical and radiographic comparison between novel locating guide design with pre-bent titanium plates and 3d printed intermediate wafer to reposition the maxilla after Le Fort 1 osteotomy in orthognathic surgery (randomized controlled clinical trial)

Detailed description

Eligible patients will be allocated randomly into 2 equal groups with 7 patients in each group according to the method that will be used to reposition the maxilla by simple randomization using computer generated random numbers. Group 1 (Study group) will be treated with locating guides to reposition the maxilla with pre-bent plates on 3d model. Group 2 (Control group) will be treated with Intermediate wafer.

Conditions

Interventions

TypeNameDescription
PROCEDUREOrthognathic surgery (lefort1)1. All patients will be treated under general anesthesia. 2. The surgical field will be scrubbed with povidone-iodine surgical scrub solution, followed by draping of the patient with sterile towels exposing only the area of surgery. 3. The surgical procedure of Le Fort I osteotomy will be performed which can be summarized as follows: 1. External reference marking 2. Incision and subperiosteal dissection 3. Maxillary osteotomy 4. Pterygomaxillary disjunction, 5. Septal, vomerine, and lateral nasal osteotomies 6. Down fracture 7. Mobilization of the maxilla 8. Application of stent in one group and the locating guide in the other group. 9. Maxillary fixation 10. Occlusal evaluation 11. Wound debridement and closure

Timeline

Start date
2022-11-15
Primary completion
2023-10-01
Completion
2023-11-01
First posted
2023-11-15
Last updated
2023-11-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06132906. Inclusion in this directory is not an endorsement.